| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 9227 | 2021 |
| How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and … WJ Paulus, C Tschöpe, JE Sanderson, C Rusconi, FA Flachskampf, ... European heart journal 28 (20), 2539-2550, 2007 | 3876 | 2007 |
| Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on … ALP Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, ... European heart journal 34 (33), 2636-2648, 2013 | 3150 | 2013 |
| 2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European Society of … H Baumgartner, J De Backer, SV Babu-Narayan, W Budts, M Chessa, ... European heart journal 42 (6), 563-645, 2021 | 1492 | 2021 |
| Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration B Oosthuyse, L Moons, E Storkebaum, H Beck, D Nuyens, K Brusselmans, ... Nature genetics 28 (2), 131-138, 2001 | 1352 | 2001 |
| miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling RF Duisters, AJ Tijsen, B Schroen, JJ Leenders, V Lentink, I van der Made, ... Circulation research 104 (2), 170-178, 2009 | 1050 | 2009 |
| Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure S Heymans, A Luttun, D Nuyens, G Theilmeier, E Creemers, L Moons, ... Nature medicine 5 (10), 1135-1142, 1999 | 1030 | 1999 |
| Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease MF Corsten, R Dennert, S Jochems, T Kuznetsova, Y Devaux, L Hofstra, ... Circulation: Cardiovascular Genetics 3 (6), 499-506, 2010 | 1000 | 2010 |
| Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC … YM Pinto, PM Elliott, E Arbustini, Y Adler, A Anastasakis, M Böhm, ... European heart journal 37 (23), 1850-1858, 2016 | 993 | 2016 |
| Myocarditis and inflammatory cardiomyopathy: current evidence and future directions C Tschöpe, E Ammirati, B Bozkurt, ALP Caforio, LT Cooper, SB Felix, ... Nature Reviews Cardiology 18 (3), 169-193, 2021 | 793 | 2021 |
| Acute viral myocarditis R Dennert, HJ Crijns, S Heymans European heart journal 29 (17), 2073-2082, 2008 | 635 | 2008 |
| European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis … AL Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, SB Felix, ... Eur Heart J 34 (33), 2636-48, 2013 | 621 | 2013 |
| Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases P Garcia-Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ... European heart journal 42 (16), 1554-1568, 2021 | 604 | 2021 |
| Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology T Eschenhagen, T Force, MS Ewer, GW De Keulenaer, TM Suter, ... European journal of heart failure 13 (1), 1-10, 2011 | 499 | 2011 |
| Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society … S Heymans, E Hirsch, SD Anker, P Aukrust, JL Balligand, ... European journal of heart failure 11 (2), 119-129, 2009 | 431 | 2009 |
| Myocardial extracellular matrix: an ever-changing and diverse entity M Rienks, AP Papageorgiou, NG Frangogiannis, S Heymans Circulation research 114 (5), 872-888, 2014 | 420 | 2014 |
| Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the … S Heymans, B Schroen, P Vermeersch, H Milting, F Gao, A Kassner, ... Circulation 112 (8), 1136-1144, 2005 | 397 | 2005 |
| Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives W Poller, S Dimmeler, S Heymans, T Zeller, J Haas, M Karakas, ... European heart journal 39 (29), 2704-2716, 2018 | 384 | 2018 |
| Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window D Vanhoutte, M Schellings, Y Pinto, S Heymans Cardiovascular research 69 (3), 604-613, 2006 | 375 | 2006 |
| The quest for new approaches in myocarditis and inflammatory cardiomyopathy S Heymans, U Eriksson, J Lehtonen, LT Cooper Journal of the American College of Cardiology 68 (21), 2348-2364, 2016 | 350 | 2016 |
Peter Carmeliethoogleraar, Universiteit van Leuven, VIBAdresse e-mail validée de kuleuven.vib.be
